| | | | | |
PYXS Pyxis Oncology, Inc. Common Stock | $3,4630 | +7,88 % | $267,73M | $504,75K | |
AIFU AIFU Inc. Class A Ordinary Share | $10,9030 | +1,52 % | $267,41M | $43,12K | |
PMO Franklin Municipal Opportunities Trust | $9,6910 | -0,71 % | $267,41M | $21,37K | |
VABK Virginia National Bankshares Corporation Common Stock | $49,2690 | +0,10 % | $267,03M | $5,17K | |
CAMP CAMP4 Therapeutics Corporation Common Stock | $4,3440 | +2,21 % | $266,70M | $113,02K | |
| $14,2200 | +0,21 % | $266,67M | $20,43K | |
| $9,3250 | +6,57 % | $266,38M | $210,34K | |
DSP Viant Technology Inc. Class A Common Stock | $12,8300 | +1,99 % | $265,87M | $132,36K | |
EGHT 8x8, Inc. Common Stock | $1,8350 | -0,27 % | $265,76M | $953,04K | |
| $19,9950 | -3,55 % | $265,37M | $74,83K | |
RILY BRC Group Holdings, Inc. Common Stock | $6,1900 | -6,21 % | $265,31M | $441,28K | |
MIN Aberdeen Intermediate Income Fund | $2,3350 | +0,22 % | $265,14M | $259,42K | |
TRDA Entrada Therapeutics, Inc. Common Stock | $6,9000 | +1,47 % | $264,76M | $141,89K | |
| $4,2190 | +3,66 % | $264,22M | $152,73K | |
OACC Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share | $10,7800 | +0,14 % | $264,01M | $8,000 | |
